Patents by Inventor Richard Kang

Richard Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220257512
    Abstract: Liposomal spherical nucleic acids that function as multivalent immune modulators are provided according to the invention. The liposomal spherical nucleic acids of the invention are useful prophylactic and therapeutic applications as well as research and diagnostic indications.
    Type: Application
    Filed: August 18, 2021
    Publication date: August 18, 2022
    Applicant: Exicure Operating Company
    Inventors: Aleksandar Filip Radovic-Moreno, Richard Kang, Subbarao Nallagatla, Christopher C. Mader, Sergei Gryaznov
  • Patent number: 11370786
    Abstract: Disclosed herein are compounds of structural Formula VIIa or VIIb: or a pharmaceutically acceptable salt thereof, and compositions thereof useful in the treatment of GLS1 mediated diseases, such as cancer. Methods of inhibition GLS1 activity in a human or animal subject are also provided.
    Type: Grant
    Filed: July 10, 2020
    Date of Patent: June 28, 2022
    Assignee: Board of Regents, The University of Texas System
    Inventors: Maria Emilia Di Francesco, Philip Jones, Timothy Heffernan, Matthew M. Hamilton, Zhijun Kang, Michael J. Soth, Jason P. Burke, Kang Le, Christopher Lawrence Carroll, Wylie S. Palmer, Richard Lewis, Timothy McAfoos, Barbara Czako, Gang Liu, Jay Theroff, Zachary Herrera, Anne Yau
  • Publication number: 20220064649
    Abstract: Aspects of the invention relate to compositions of spherical nucleic acids (SNAs) composed of a liposome or lipoplex complex having an oligonucleotide shell with CpG oligonucleotides positioned on the exterior of the liposome or lipoplex. The invention also relates to methods of treating subjects and of inducing cytokine expression in a subject using the compositions described herein.
    Type: Application
    Filed: April 15, 2021
    Publication date: March 3, 2022
    Applicant: Exicure, Inc.
    Inventors: Bart Anderson, Subbarao Nallagatla, Richard Kang, Ekambar Kandimalla
  • Patent number: 11123294
    Abstract: Liposomal spherical nucleic acids that function as multivalent immune modulators are provided according to the invention. The liposomal spherical nucleic acids of the invention are useful prophylactic and therapeutic applications as well as research and diagnostic indications.
    Type: Grant
    Filed: September 12, 2019
    Date of Patent: September 21, 2021
    Assignee: Exicure Operating Company
    Inventors: Aleksandar Filip Radovic-Moreno, Richard Kang, Subbarao Nallagatla, Christopher C. Mader, Sergei Gryaznov
  • Publication number: 20210137232
    Abstract: Disclosed herein is a case for a portable electronic device. The case has a back wall and a plurality of side walls for retaining the portable electronic device. The back wall includes a storage area. A cover is hingedly attached to the back wall to selectively cover the storage area. The storage area includes a grip for retaining edges of data cards.
    Type: Application
    Filed: October 19, 2020
    Publication date: May 13, 2021
    Inventors: Harsh Gandhi, Benjamin MacBeth, Jeffrey Lienemann, Richard Kang, Tai Hoon K. Matlin, Steve Carson
  • Publication number: 20210002640
    Abstract: Compositions related to spherical nucleic acids (SNAs) and structures with antisense oligonucleotides and methods of treatment of diseases and disorders are disclosed herein.
    Type: Application
    Filed: February 28, 2019
    Publication date: January 7, 2021
    Applicant: Exicure, Inc.
    Inventors: Richard Kang, Subbarao Nallagatla, Bart Anderson, Ekambar Kandimalla, Michael Mutolo
  • Patent number: 10842238
    Abstract: Disclosed herein is an electronic device encasement which not only encases and protects the electronic device, it allows for storage and presentation of one or more data cards. As the encasement device operator initiates access to the stored data card by opening a protective storage cover, the accessing action initiates a subsequent mechanical response which presents the card by a separating action from the encasement and the other possible stored items, as to allow for easier access and use of the one or more data cards. The storage and presentment mechanisms include a plurality of pockets, grips, and other structures to secure and present the cards.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: November 24, 2020
    Assignee: Fellowes Mobile LLC
    Inventors: Harsh Gandhi, Benjamin MacBeth, Jeffrey Lienemann, Richard Kang, Tai Hoon K. Matlin, Steve Carson
  • Publication number: 20200339996
    Abstract: TNF? antisense oligonucleotides are provided herein. Methods of treating TNF? diseases or disorders using the TNF? antisense oligonucleotides and related products are provided.
    Type: Application
    Filed: July 16, 2020
    Publication date: October 29, 2020
    Applicant: Exicure, Inc.
    Inventors: Christopher C. Mader, Tiffany L. Halo, Sergei Gryaznov, Richard Kang, Weston Daniel
  • Publication number: 20200308579
    Abstract: Aspects of the invention relate to antisense oligonucleotides directed to the interleukin 17 receptor (IL-17R), and other targets. Spherical nucleic acid formulations or compositions of antisense oligonucleotides and related methods of treatment are also provided.
    Type: Application
    Filed: May 5, 2017
    Publication date: October 1, 2020
    Applicant: Exicure, Inc.
    Inventor: Richard Kang
  • Publication number: 20200297867
    Abstract: The invention relates to a method of synthesizing liposomes and liposomal spherical nucleic acids with hydrophobic molecules functionalized to the surface. The lipid particles contain one or more agents that elicit an immune response.
    Type: Application
    Filed: February 1, 2017
    Publication date: September 24, 2020
    Applicant: Exicure, Inc.
    Inventors: Richard Kang, Sagar Anantatmula, Rishika Agarwal, Merideth Burkhart, Bart Anderson
  • Patent number: 10760080
    Abstract: TNF? antisense oligonucleotides are provided herein. Methods of treating TNF? diseases or Initial Screen of Phosphodiester disorders using the TNF? antisense oligonucleotides and related products are provided.
    Type: Grant
    Filed: January 16, 2019
    Date of Patent: September 1, 2020
    Assignee: Exicure, Inc.
    Inventors: Christopher C. Mader, Tiffany L. Halo, Sergei Gryaznov, Richard Kang, Weston Daniel
  • Publication number: 20200255837
    Abstract: Aspects of the invention relate to compositions of spherical nucleic acids (SNAs) composed of a liposome or lipoplex complex having an oligonucleotide shell with CpG oligonucleotides positioned on the exterior of the liposome or lipoplex. The invention also relates to methods of treating subjects and of inducing cytokine expression in a subject using the compositions described herein.
    Type: Application
    Filed: May 5, 2017
    Publication date: August 13, 2020
    Applicant: Exicure, Inc.
    Inventors: Bart Anderson, Subbarao Nallagatla, Richard Kang, Ekambar Kandimalla
  • Publication number: 20200188521
    Abstract: Spherical nucleic acids (SNA) carrying self-aggregating oligonucleotides are described herein. Compositions of the SNA include discrete nanostructures that are not aggregated. Related methods are also described.
    Type: Application
    Filed: April 27, 2018
    Publication date: June 18, 2020
    Applicant: Exicure, Inc.
    Inventors: Richard Kang, Subbarao Nallagatla, Bart Anderson, Ekambar Kandimalla
  • Publication number: 20200069587
    Abstract: Liposomal spherical nucleic acids that function as multivalent immune modulators are provided according to the invention. The liposomal spherical nucleic acids of the invention are useful prophylactic and therapeutic applications as well as research and diagnostic indications.
    Type: Application
    Filed: September 12, 2019
    Publication date: March 5, 2020
    Applicant: Exicure, Inc.
    Inventors: Aleksandar Filip Radovic-Moreno, Richard Kang, Subbarao Nallagatla, Christopher C. Mader, Sergei Gryaznov
  • Patent number: 10434064
    Abstract: Liposomal spherical nucleic acids that function as multivalent immune modulators are provided according to the invention. The liposomal spherical nucleic acids of the invention are useful prophylactic and therapeutic applications as well as research and diagnostic indications.
    Type: Grant
    Filed: June 4, 2015
    Date of Patent: October 8, 2019
    Assignee: Exicure, Inc.
    Inventors: Aleksandar Filip Radovic-Moreno, Richard Kang, Subbarao Nallagatla, Christopher C. Mader, Sergei Gryaznov
  • Publication number: 20190298024
    Abstract: Disclosed herein is an electronic device encasement which not only encases and protects the electronic device, it allows for storage and presentation of one or more data cards. As the encasement device operator initiates access to the stored data card by opening a protective storage cover, the accessing action initiates a subsequent mechanical response which presents the card by a separating action from the encasement and the other possible stored items, as to allow for easier access and use of the one or more data cards. The storage and presentment mechanisms include a plurality of pockets, grips, and other structures to secure and present the cards.
    Type: Application
    Filed: March 29, 2019
    Publication date: October 3, 2019
    Inventors: Harsh Gandhi, Benjamin MacBeth, Jeffrey Lienemann, Richard Kang, Tai Hoon K. Matlin, Steve Carson
  • Publication number: 20190225968
    Abstract: Aspects of the invention relate to compositions of spherical nucleic acids (SNAs) composed of a liposome or lipoplex complex having an oligonucleotide shell with CpG oligonucleotides positioned on the exterior of the liposome or lipoplex. The invention also relates to methods of treating subjects and of inducing cytokine expression in a subject using the compositions described herein.
    Type: Application
    Filed: May 5, 2017
    Publication date: July 25, 2019
    Applicant: Exicure, Inc.
    Inventors: Bart Anderson, Subbarao Nallagatla, Richard Kang, Ekambar Kandimalla
  • Publication number: 20190211338
    Abstract: TNF? antisense oligonucleotides are provided herein. Methods of treating TNF? diseases or disorders using the TNF? antisense oligonucleotides and related products are provided.
    Type: Application
    Filed: January 16, 2019
    Publication date: July 11, 2019
    Applicant: Exicure, Inc.
    Inventors: Christopher C. Mader, Tiffany L. Halo, Sergei Gryaznov, Richard Kang, Weston Daniel
  • Patent number: 10208310
    Abstract: TNF? antisense oligonucleotides are provided herein. Methods of treating TNF? diseases or disorders using the TNF? antisense oligonucleotides and related products are provided.
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: February 19, 2019
    Assignee: Exicure, Inc.
    Inventors: Christopher C. Mader, Tiffany L. Halo, Sergei Gryaznov, Richard Kang, Weston Daniel
  • Patent number: D819369
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: June 5, 2018
    Assignee: Fellowes, Inc.
    Inventor: Richard Kang